
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66363
Obstetrics/Gynecology
A Case Report of Successful Live Pregnancy Following Embryo Transfer in a Thin Endometrium
Muacevic Alexander
Adler John R
Ali Jijisha 1
Magray Shazia 2
Ahmed Eman 3
Talo Sami 4
1 Obstetrics and Gynaecology, Mediclinic Welcare Hospital, Mediclinic Middle East, Dubai, ARE
2 Reproductive Medicine and Infertility, Bourn Hall Fertility Centre, Mediclinic Middle East, Dubai, ARE
3 Clinical Embryology, Bourn Hall Fertility Centre, Mediclinic Middle East, Dubai, ARE
4 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, ARE
Jijisha Ali jijshaji@gmail.com
7 8 2024
8 2024
16 8 e663637 8 2024
Copyright © 2024, Ali et al.
2024
Ali et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/275799-a-case-report-of-successful-live-pregnancy-following-embryo-transfer-in-a-thin-endometrium
Managing a thin endometrium is a common challenge in assisted reproductive treatments. The thickness of the endometrium is crucial for embryo implantation, with younger patients generally having higher success rates even with a thinner lining. A frozen embryo transfer cycle often allows for a more thorough assessment of the endometrium compared to a fresh transfer. We present a case of a 36-year-old woman who presented to our fertility center with primary infertility for six years. Despite having regular menstrual cycles, her endometrial thickness consistently measured between 5 and 6.0 mm on ultrasonography. She underwent ovarian stimulation using an antagonist protocol, resulting in the retrieval of oocytes and the freezing of three embryos. However, three frozen embryo transfer cycles were cancelled due to inadequate endometrial thickness (ranging from 4.3 to 5.2 mm). In the fourth cycle, she was treated with gonadotropins with the goal of achieving two to three follicles and improved endometrial thickness. Triggering was performed on day 15, followed by the transfer of one frozen embryo at an endometrial thickness of 5.7 mm. Her beta-human chorionic gonadotropin (hCG) level was positive, with an initial value of 136.9 mIU/mL, and she subsequently delivered a healthy baby. This case highlights the challenges of managing a thin endometrium in assisted reproductive techniques. Through persistent efforts and tailored treatment protocols, a successful live birth was achieved despite recurrent thin endometrium. This case underscores the importance of individualized treatment strategies in overcoming endometrial challenges in infertility treatments.

assisted reproductive technologies
infertility
frozen embryo transfer
recurrent
thin endometrium
==== Body
pmcIntroduction

The effectiveness of assisted reproductive technologies (ARTs) largely relies on the implantation of a genetically healthy embryo into a receptive endometrium [1]. It is suggested that two-thirds of implantation failures are due to poor endometrial receptivity and disrupted communication between the embryo and the endometrium [2]. Pregnancy rates tend to rise as endometrial thickness (EMT) increases from 8 to 14 mm [3]. An EMT of less than 7 mm during the implantation window (typically between days 19 and 23 of the menstrual cycle), as observed on ultrasound, is generally classified as a thin endometrium.

Research indicates that embryo implantation and live birth rates improve when the EMT exceeds 8 mm on the day of trigger shot administration [4]. However, the minimum EMT associated with a successful full-term live birth in assisted reproduction is reported to be 3.5 mm [5]. The endometrium should be assessed using a transvaginal probe with the bladder empty. This method places the transducer closer to the endometrium and employs a higher frequency (≥5 to 8 MHz). This results in enhanced resolution and visualization, though it reduces penetration depth. The EMT should be measured in the sagittal plane or long axis, taking the measurement from the thickest echogenic area from one stratum basalis interface across the endometrial canal to the opposite stratum basalis interface. It is important not to include the surrounding inner myometrial lucency in this measurement [6].

A persistently thin endometrium is often linked to past extensive curettage, infections, Asherman's syndrome, or uterine irradiation [7]. Efforts to enhance overall endometrial growth and pattern have not yet been validated. Various treatments have been attempted, including operative hysteroscopy, intrauterine infusion of granulocyte colony-stimulating factor (G-CSF), and methods to improve endometrial blood supply such as aspirin, vitamin E, pentoxifylline, L-arginine, or sildenafil. Regenerative medicine approaches have also been explored, and certain studies have suggested that intrauterine platelet-rich plasma (PRP) can enhance EMT [8]. However, none of these methods have been shown to consistently improve cases of thin endometrium.

Case presentation

A 36-year-old woman with a six-year history of primary infertility presented to our fertility center. She reported regular menstrual cycles and had previously undergone two laparoscopic surgeries for Grade IV endometriosis. Her anti-Müllerian hormone (AMH) level was measured at 0.5 ng/mL (reference range: 1.0-4.0 ng/mL), indicating diminished ovarian reserve. The rest of her endocrine profile was within normal limits, except for an elevated prolactin level. Her husband's semen analysis was normal. Ultrasonography performed on day 2 of her menstrual cycle revealed five antral follicles in the right ovary and three in the left ovary. The EMT on day 2 was 4.8 mm (reference range: 7-8 mm). She was prescribed cabergoline 0.25 mg weekly and planned for a short antagonist cycle of ART.

She commenced treatment with follitropin alfa 300 IU daily starting from day 2 of the menstrual cycle, as shown in Table 1. On day 7 of the ART cycle, cetrorelix acetate 0.25 mg was added to prevent premature ovulation. On day 10, ultrasonography showed an EMT of 6 mm. The patient was then given menotropins (a combination of follicle-stimulating hormone (FSH) 225 IU and luteinizing hormone (LH) 225 IU), and cetrorelix acetate was continued. On day 12, ultrasonography showed a very thin endometrial lining of 5.5 mm (reference range: 7-8 mm). Triggering was performed on the same night, and egg retrieval occurred 36 hours later. Three embryos of grade AB were successfully frozen (Tables 1, 2).

Table 1 Folliculogram showing the short antagonistic cycle of ART.

OPU: oocyte pick-up; ART: assisted reproductive technology; EMT: endometrial thickness; FSH: follicle-stimulating hormone; LH: luteinizing hormone.

OPU cycle 1	Day 2	Day 7	Day 9	Day 12	DAY 14	
EMT (reference range: 7-8 mm)	4.8 mm	5 mm	6.0 mm	5.5 mm	5.8 mm	
Right ovary: follicle number	Three antral follicles	Four follicles	Three follicles	Five follicles	OPU	
Right ovary: follicle size	2-3 mm	10-12 mm	16-13 mm	14-20 mm	
Left ovary: follicle number	Five antral follicles	Five follicles	Four follicles	Five follicles	
Left ovary: follicle size	2-3mm	10-12 mm	13-16 mm	14-17 mm	
Gonal-F (follitropin alfa)  	Started 300 IU	300 IU  to continue	Stopped Gonal-F and started menotropins	Stopped menotropins	
Cetrorelix acetate	Was on Gonal F only	0.25 mg added to continue	0.25 mg to continue	0.25 mg last dose	
Menotropins (FSH 225 IU and LH 225 IU)	Was on Gonal F only	225 IU started to continue till Day 11	Triggering done with choriogonadotropin alfa injection (Ovitrelle 250 mcg equivalent to 6500 IU) at night	

Table 2 Folliculogram showing the FET cycle.

EMT: endometrial thickness; FET: frozen embryo transfer; FSH: follicle-stimulating hormone; LH: luteinizing hormone.

FET cycle 1	Day 3	Day 12	Day 15	Day 22	
EMT (reference range: 7-8 mm)	5.2 mm	5.5 mm	5.5 mm	5.7 mm	
Cetrorelix acetate	Was on menotropins 75 IU only	0.25 mg started	0.25 mg last dose	FET done	
Menotropins (FSH 75 IU and LH 75 IU)	75 IU started and to continue	75 IU to continue till Day 14	Triggering done with choriogonadotropin alfa injection (Ovitrelle 250 mcg) at night.	

For the subsequent frozen embryo transfer (FET) cycle, the patient was started on estradiol valerate 4 mg three times daily, both orally and vaginally, due to thin endometrium noted on day 2. However, by day 9, the endometrial lining was only 4.3 mm (reference range: 7-8 mm), with fluid present in the uterine cavity. The cycle was cancelled due to persistent thin endometrium and intrauterine fluid. A hysteroscopy was performed and revealed a normal endometrium, as shown in Figure 1. Similar ultrasound findings were seen after three months, and the patient was started on estrogen patches (100 mcg every three days) and letrozole 5 mg for seven days. This cycle was also cancelled due to persistent intrauterine fluid and thin endometrium.

Figure 1 Hysteroscopic image revealing a normal endometrium in the patient.

In the subsequent cycle, the patient was administered gonadotropins (FSH 75 IU and LH 75 IU) from day 3. Cetrotelix acetate 0.25 mg was started on day 12. By day 12, the EMT was 5.5 mm (reference range: 7-8 mm). Choriogonadotropin alfa was administered on day 15, followed by single embryo transfer of grade AB on day 22, with an EMT of 5.7 mm (reference range: 7-8 mm) at the time of transfer (Figure 2). The patient was started on estradiol valerate 2 mg twice daily and progesterone soft gel capsules twice daily. Beta-human chorionic gonadotropin (hCG) measured on day 31 was positive, with a value of 136.9 mIU/mL (reference range: <5 mIU/mL). She subsequently delivered a healthy female baby weighing 3.1 kg at 37 weeks of gestation.

Figure 2 Ultrasound showing the EMT of the patient at the time of embryo transfer.

EMT: endometrial thickness.

Discussion

Managing a thin endometrium is a frequent challenge for patients undergoing assisted reproduction. Clinical practice typically involves measuring EMT. Despite conflicting study results and a lack of consensus on the correlation between EMT and IVF outcomes, an EMT of less than 7 mm is generally considered unfavorable. The EMT is measured in the sagittal plane or long axis, taking the measurement from the thickest echogenic area from one stratum basalis interface across the endometrial canal to the opposite stratum basalis interface, as shown in Figure 3.

Figure 3 Ultrasound showing the measurement technique for EMT.

EMT: endomterial thickness.

Recent studies indicate that EMT on the day of hCG trigger can influence pregnancy outcomes, with a thin endometrium posing a clinical challenge [9]. To address this, various strategies have been employed in clinical practice to enhance endometrial growth. These strategies include the administration of estrogen, low-dose aspirin, vitamin E, vaginal sildenafil citrate, and intrauterine perfusion with granulocyte colony-stimulating factor (G-CSF). These methods have not shown consistent improvement in EMT. For example, a 2024 case report by Huang et al. noted that EMT did not significantly increase with the use of aspirin. However, the study documented a successful pregnancy with an EMT of 3.8 mm [10]. This suggests that even with a thin endometrium, appropriate interventions can lead to successful pregnancies. Agrawal et al. reported another case in 2022 where a successful pregnancy was achieved in a patient with a persistently thin endometrium [11]. For patients with a thin endometrium, it is important to focus not only on increasing thickness but also on improving endometrial blood supply and morphology to enhance pregnancy rates [10].

In a 2013 study by Chen and Chen, three patients who previously failed to develop an EMT of at least 6 mm over at least three cycles, including natural cycles, extended estrogen treatment cycles with aspirin, or letrozole stimulation cycles, achieved significant endometrial growth and successfully conceived following the administration of 20 mg of tamoxifen daily for five days [12].

In our case report, we achieved successful pregnancy with an EMT of 5.7 mm (reference range: 7-8 mm). Our patient was stimulated with gonadotropins for 14 days, followed by trigger with choriogonadotropin alfa 250 mcg on the 15th day. Her EMT remained in the range of 5-6.0 mm. Clinicians often change stimulation medications when faced with a thin endometrium. A meta-analysis by Weiss et al. found that clomiphene and letrozole were both linked to a thinner endometrium compared to gonadotropins in ovarian stimulation cycles [13]. When a clinician encounters a persistently thin endometrium, it is important to evaluate the patient's condition and preferences. Clinicians should make every effort to employ a variety of methods to address the issue. It is important to note that for patients with a thin endometrium, the potential to achieve a thicker endometrium in future ovarian stimulation cycles is uncertain.

Furthermore, in cases of patients with a thin endometrium, it is recommended to opt for a frozen cycle instead of a fresh transfer. This approach allows for a more detailed assessment of the endometrium and offers the advantage of postponing the transfer if the lining has not developed adequately [14]. Moreover, for women over 35 years of age, FETs have shown significantly higher rates of biochemical pregnancy, clinical pregnancy, and live births compared to fresh embryo transfers [15].

Conclusions

This case highlights the challenges and successful outcomes of assisted reproductive technology (ART) in a patient with primary infertility and severe endometriosis. Despite multiple cycles complicated by a persistently thin endometrium and intrauterine fluid, the use of gonadotropins, estrogen therapy, and careful monitoring resulted in a successful pregnancy and delivery. It is important to conduct an endometrial assessment prior to the index cycle in such cases, as young patients may still have a reasonable chance of implantation even with a thin endometrium. For those preparing for a FET, the status of the endometrium during the stimulation cycle should be carefully considered. Physicians must weigh the potential outcomes of proceeding with treatment against the possibility of exploring alternative approaches for patients with a thin endometrium. Currently, there is limited evidence supporting specific protocols or adjuvants that can significantly enhance pregnancy outcomes for these patients. Further research is needed to establish effective strategies for managing thin endometrium in assisted reproduction.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Jijisha Ali, Shazia Magray, Eman Ahmed , Sami Talo

Acquisition, analysis, or interpretation of data:  Jijisha Ali, Shazia Magray, Eman Ahmed , Sami Talo

Drafting of the manuscript:  Jijisha Ali, Shazia Magray, Eman Ahmed , Sami Talo

Critical review of the manuscript for important intellectual content:  Jijisha Ali, Shazia Magray, Eman Ahmed , Sami Talo

Supervision:  Jijisha Ali, Shazia Magray
==== Refs
References

1 Endocrinology of pregnancy Endotext [Internet] Tal R Taylor HS South Dartmouth (MA) MDText.com 2000 https://pubmed.ncbi.nlm.nih.gov/25905197/
2 Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis Hum Reprod Update Craciunas L Gallos I Chu J Bourne T Quenby S Brosens JJ Coomarasamy A 202 223 25 2019 30624659
3 Parabolic trend in endometrial thickness at embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cases with clinical pregnancy evidence Fertil Steril Lamanna G Scioscia M Lorusso F Serrati G Selvaggi LE Depalo R 1272 1274 90 2008 17953948
4 The effect of endometrial thickness on the day of hCG administration on pregnancy outcome in the first fresh IVF/ICSI cycle Gynecol Endocrinol Fang R Cai L Xiong F Chen J Yang W Zhao X 473 476 32 2016 26743235
5 Live birth after embryo transfer in an unresponsive thin endometrium Gynecol Endocrinol Cruz F Bellver J 481 484 30 2014 24650368
6 Ultrasonographic assessment of endometrial thickness: a review J Obstet Gynaecol Can Persadie RJ 131 136 24 2002 12196878
7 Thin unresponsive endometrium--a possible complication of surgical curettage compromising ART outcome J Assist Reprod Genet Shufaro Y Simon A Laufer N Fatum M 421 425 25 2008 18797990
8 Intrauterine administration of autologous platelet-derived growth factor concentrate (aka autologous blood cell derivative) improves the endometrial thickness in 'Thin' endometrium in the frozen embryo transfer cycle J Obstet Gynaecol India Kumar P Mundkur A Sai Bhavna D 108 114 73 2023 37916017
9 The impact of endometrial thickness (EMT) on the day of human chorionic gonadotropin (hCG) administration on pregnancy outcomes: a 5-year retrospective cohort analysis in Malaysia Fertil Res Pract Chan JM Sukumar AI Ramalingam M Ranbir Singh SS Abdullah MF 5 4 2018 30116547
10 Successful live birth of thin endometrium: a case report Medicine (Baltimore) Huang B Lu D Kong Y Ma L 0 103 2024
11 Successful pregnancy in recurrent thin endometrium: a case report Fertil Sci Res Agrawal M Agrawal SK Agrawal RB Agrawal A Agrawal S 68 70 9 2022
12 Successful pregnancy in recurrent thin endometrium with new uses for an old drug J IVF Reprod Med Genet Chen X Chen S-l 110 1 2013
13 Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis Hum Reprod Weiss NS van Vliet MN Limpens J 1009 1018 32 2017 28333207
14 Fresh versus frozen embryo transfer in women with thin endometrium: a retrospective cohort study Ann Transl Med Guo Z Chu R Zhang L Yu Q Yan L Ma J 1435 8 2020 33313180
15 Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience J Obstet Gynaecol Acet F Hortu I Sahin G Goker EN Tavmergen E 276 280 42 2022 33913396
